13F-HR filed by Soleus Capital Management, L.P.
Soleus Capital Management, L.P. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 22:26:02 UTC, with 97 holding rows worth $2,813,021,888.
- Accession
- 0001802630-26-000008
- Filer
- CIK 1802630
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
13F report for Q3 2026
A holdings report, 97 entries on the cover page, a total value of $2,813,021,888 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,813,021,888 with VALUE read as dollars as filed, 13F file number 028-20043. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 1,139,700 | $379,018,632 | dollars as filed | |
| INSULET CORP COM | 45784P101 | Stock | 1,726,500 | $225,256,455 | dollars as filed | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 9,425,776 | $150,341,127 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 2,556,168 | $142,583,051 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 259,000 | $140,349,510 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 1,682,760 | $133,813,075 | dollars as filed | |
| RIGEL PHARMACEUTICALS INC | 766559702 | COMMON STOCK | 1,843,504 | $88,764,718 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 1,206,828 | $83,705,590 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 5,112,000 | $74,941,920 | dollars as filed | |
| BETA BIONICS INC | 08659B102 | COMMON STOCK | 3,743,714 | $71,055,692 | dollars as filed | |
| ANI PHARMACEUTICALS INC | 00182C103 | COM | 975,500 | $70,870,075 | dollars as filed | |
| VERICEL CORP | 92346J108 | COM | 1,554,059 | $62,379,928 | dollars as filed | |
| GERON CORP | 374163103 | COM | 46,768,659 | $57,525,451 | dollars as filed | |
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 1,684,512 | $54,392,892 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 49,350 | $47,322,209 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 1,081,000 | $45,315,520 | dollars as filed | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 3,218,000 | $44,279,680 | dollars as filed | |
| EVOLUS INC | 30052C107 | COM | 5,090,000 | $40,720,000 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 1,543,000 | $40,642,620 | dollars as filed | |
| PROGYNY INC COM | 74340E103 | Stock | 1,582,000 | $39,850,580 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 2,727,727 | $39,061,051 | dollars as filed | |
| NUVECTIS PHARMA INC | 67080T108 | COMMON STOCK | 1,710,658 | $36,129,097 | dollars as filed | |
| EDAP TMS S A | 268311107 | SPONSORED ADR | 7,309,254 | $32,672,365 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 1,019,000 | $29,031,310 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 286,966 | $27,204,377 | dollars as filed | |
| SILENCE THERAPEUTICS PLC | 82686Q101 | ADS | 2,385,700 | $26,075,701 | dollars as filed | |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 11,225,000 | $23,067,375 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 862,000 | $22,265,460 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 1,085,550 | $21,591,590 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 892,163 | $21,153,185 | dollars as filed | |
| INHIBRX BIOSCIENCES INC | 45720N103 | COM | 210,000 | $21,016,800 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 1,272,355 | $20,357,680 | dollars as filed | |
| PALISADE BIO INC | 696389402 | COMMON STOCK | 14,996,154 | $20,244,808 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 497,706 | $20,167,047 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 802,297 | $20,017,310 | dollars as filed | |
| BIODESIX INC COM | 09075X207 | Stock | 667,835 | $19,921,518 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 604,000 | $19,158,880 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 147,000 | $16,778,580 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 56,515 | $16,458,863 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 1,170,928 | $16,451,538 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 218,958 | $16,336,456 | dollars as filed | |
| CONMED CORP COM | 207410101 | Stock | 347,333 | $16,057,205 | dollars as filed | |
| ETON PHARMACEUTICALS INC | 29772L108 | COMMON STOCK | 308,101 | $15,864,120 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 710,198 | $15,816,109 | dollars as filed | |
| ORGANOGENESIS HOLDINGS INC | 68621F102 | COMMON STOCK | 11,300,951 | $15,482,303 | dollars as filed | |
| GRAIL INC | 384747101 | COM | 108,500 | $15,203,020 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 258,897 | $15,176,542 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 329,987 | $13,397,472 | dollars as filed | |
| AMNEAL PHARMACEUTICALS INC | 03168L105 | COM STK CL A | 658,000 | $13,252,120 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 3,378,378 | $13,209,458 | dollars as filed | |
| SEPTERNA INC COM | 81734D104 | Stock | 330,000 | $12,912,900 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 615,990 | $11,580,612 | dollars as filed | |
| SANOFI SA SPONSORED ADR | 80105N105 | ADR | 275,000 | $11,338,250 | dollars as filed | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 3,357,981 | $11,182,077 | dollars as filed | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 600,358 | $10,938,523 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 445,025 | $9,732,697 | dollars as filed | |
| Yarrow Bioscience, Inc. | 92941V407 | Common Stock, $0.0001 par value | 416,993 | $9,390,682 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 230,274 | $9,356,033 | dollars as filed | |
| TWIST BIOSCIENCE CORP | 90184D100 | COM | 47,532 | $9,185,084 | dollars as filed | |
| ASTRAZENECA PLC ORD | G0593M107 | ADR | 52,500 | $8,477,175 | dollars as filed | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 551,977 | $8,180,299 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 205,000 | $7,623,950 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 36,249 | $7,440,470 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 121,120 | $7,267,200 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 699,149 | $6,620,941 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 7,524,958 | $6,547,466 | dollars as filed | |
| PULMONX CORP | 745848101 | COM | 3,088,323 | $5,898,697 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 383,594 | $5,880,496 | dollars as filed | |
| CASTLE BIOSCIENCES INC | 14843C105 | COMMON STOCK | 141,137 | $5,014,598 | dollars as filed | |
| FIRST TRACKS BIOTHERAPEUTICS | 337185102 | ORD SHS *A* | 140,500 | $4,979,320 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 25,552 | $4,195,383 | dollars as filed | |
| TCGX ACQUISITION CORP | G8708J109 | COM | 225,000 | $2,814,750 | dollars as filed | |
| Electra Therapeutics, Inc. | 284825106 | Common Stock, $0.0001 par value per share | 250,000 | $2,812,500 | dollars as filed | |
| SATELLOS BIOSCIENCE INC | 80401L803 | COM | 330,102 | $2,805,867 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 368,123 | $2,661,529 | dollars as filed | |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 672,039 | $2,130,364 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 7,063,141 | $2,121,768 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 706,280 | $1,956,396 | dollars as filed | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 100,000 | $1,631,000 | dollars as filed | |
| WAYSTAR HLDG CORP | 946784105 | COM | 50,000 | $1,267,000 | dollars as filed | |
| MANNKIND CORP COM NEW | 56400P706 | Stock | 300,100 | $1,170,390 | dollars as filed | |
| CERUS CORP | 157085101 | COM | 450,000 | $1,071,000 | dollars as filed | |
| QIAGEN NV ORD SHARES | N72482156 | Stock | 20,000 | $875,200 | dollars as filed | |
| APREA THERAPEUTICS INC | 03836J201 | COM NEW | 1,000,000 | $750,000 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 1,045,708 | $698,324 | dollars as filed | |
| NEXTCURE INC | 65343E207 | COM NEW | 90,000 | $450,900 | dollars as filed | |
| INDIVIOR PHARMACEUTICALS INC | 45579U109 | COM | 10,000 | $358,500 | dollars as filed | |
| PROCESSA PHARMACEUTICALS INC | 74275C403 | COM SHS | 160,943 | $263,947 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 1,524 | $258,806 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 2,500 | $245,750 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 660 | $242,273 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 20,971 | $234,456 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 20,000 | $210,800 | dollars as filed | |
| ATTOVIA THERAPEUTICS INC | 04987L102 | COM | 10,000 | $171,400 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 90,000 | $146,250 | dollars as filed | |
| RXSIGHT INC | 78349D107 | COM | 20,000 | $98,000 | dollars as filed | |
| SOPHIA GENETICS SA | H82027105 | ORDINARY SHARES | 10,000 | $83,800 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001802630-26-000008 | this filing | 2026-11-16 |